Virginia Jamieson
Chief Medical Officer
Clinical Development
Kuros Biosciences
Switzerland
Biography
Virginia Jamieson was appointed Chief Medical Officer (CMO) in March 2016 responsible for overseeing the clinical development of the projects. She previously worked for Kuros Biosurgery AG from 2005 until 2012 as medical director and then as CMO leading the clinical and regulatory functions. Dr. Jamieson has over 25 years of experience in the pharmaceutical industry covering all phases of development in a wide variety of therapeutic areas, following a career in anesthesia. She obtained a BSc in Medical Sciences and Medical Degree from Edinburgh University, Scotland, a post-graduate fellowship in anesthesia from the Royal College of Anaesthetists in London, UK, and a Diploma in pharmaceutical medicine from the Royal College of Physicians in London, UK. Dr. Jamieson is a British citizen.
Research Interest
Clinical development
